ChristopherFrancisMojcikMD

PubMed

• 31 citations
  Evaluation of the Short-, Mid-, and Long-Term Effects of Tofacitinib on Lymphocytes in Patients With Rheumatoid Arthritis.
  Ronald F van Vollenhoven, Eun Bong Lee, Sander Strengholt, Christopher F. Mojcik, Hernan Valdez, Sriram Krishnaswami, Pinaki Biswas, Irina Lazariciu, Anasuya Hazra, Ja...> ;Arthritis & Rheumatology. 2019 May 1
• 13 citations
  Modified- versus immediate-release tofacitinib in Japanese rheumatoid arthritis patients: a randomized, phase III, non-inferiority study
  Yoshiya Tanaka, Naonobu Sugiyama, Shigeyuki Toyoizumi, Tatjana Lukic, Manisha Lamba, Richard Zhang, Connie Chen, Thomas C. Stock, Hernan Valdez, Christopher F. Mojcik,...> ;Rheumatology. 2019 Jan 1
• 22 citations
  Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy v...
  Kent J. Weinhold, Jack F. Bukowski, Todd V. Brennan, Robert J. Noveck, Janet Staats, Liwen Lin, Linda Stempora, Constance Hammond, Ann Wouters, Christopher F. Mojcik, ...> ;Clinical Immunology. 2018 Jun 1
• 91 citations
  The safety and immunogenicity of live Zoster Vaccination in patients with rheumatoid arthritis before starting Tofacitinib: a randomized phase II trial
  Kevin L. Winthrop, Ann Wouters, Ernest Choy, Koshika Soma, Jennifer Hodge, Chudy I. Nduaka, Pinaki Biswas, Elie Needle, Sherry Passador, Christopher F. Mojcik, William...> ;Arthritis & Rheumatology. 2017 Oct 1
• 278 citations
  Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): ...
  Roy Fleischmann, Eduardo Mysler, Stephen Hall, Alan J Kivitz, Robert J. Moots, Zhen Luo, Ryan DeMasi, Koshika Soma, Richard Zhang, Liza Takiya, Svitlana Tatulych, Chri...> ;Lancet. 2017 Jul 29
• 529 citations
  Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
  Russell P. Rother, Scott A. Rollins, Christopher F. Mojcik, Robert A. Brodsky, Leonard Bell> ;Nature Biotechnology. 2007 Nov 1
• 836 citations
  The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.
  Peter Hillmen, Neal S. Young, Jörg Schubert, Robert A. Brodsky, Gérard Socié, Petra Muus, Alexander Röth, Jeff Szer, Modupe O. Elebute, Ryotaro Nakamura, Paul Browne, ...> ;The New England Journal of Medicine. 2006 Sep 21
• 134 citations
  Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study
  Abhinav Goyal, Kenneth W. Mahaffey, Jyotsna Garg, Jose C. Nicolau, Judith S. Hochman, W. Douglas Weaver, Pierre Théroux, Gustavo B.F. Oliveira, Thomas G. Todaro, Chris...> ;European Heart Journal. 2006 Jun 1
• 151 citations
  Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria.
  Anita Hill, Peter Hillmen, Stephen J. Richards, Dupe Elebute, Judith C. Marsh, Jason Yongsheng Chan, Christopher F. Mojcik, Russell P. Rother> ;Blood. 2005 Oct 1
• 55 citations
  Reproducibility of the semiflexed (metatarsophalangeal) radiographic knee position and automated measurements of medial tibiofemoral joint space width in a multicenter...
  J. Chris Buckland-Wright, Rupert Ward, Charles Peterfy, Christopher F Mojcik, Richard L Leff> ;The Journal of Rheumatology. 2004 Aug 1
• 138 citations
  Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial.
  Edward D. Verrier, Stanton K. Shernan, Kenneth M. Taylor, Frans Van de Werf, Mark F. Newman, John C. Chen, Michel Carrier, Axel Haverich, Kevin J. Malloy, Peter X. Ada...> ;JAMA. 2004 May 19
• 79 citations
  Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary b...
  Stanton K. Shernan, Jane C. K. Fitch, Nancy A. Nussmeier, John C. Chen, Scott A. Rollins, Christopher F. Mojcik, Kevin J. Malloy, Thomas G. Todaro, Thomas G. Filloon, ...> ;The Annals of Thoracic Surgery. 2004 Mar 1
• 433 citations
  Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.
  Peter Hillmen, Claire Hall, Judith C. W. Marsh, Modupe O. Elebute, Michael P Bombara, Beth E. Petro, Matthew J. Cullen, Stephen J. Richards, Scott A. Rollins, Christop...> ;The New England Journal of Medicine. 2004 Feb 5
• 137 citations
  Effect of Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Fibrinolysis in Acute Myocardial Infarction The COMPlement inhibition in myocardial inf...
  Kenneth W. Mahaffey, Christopher B. Granger, Jose C. Nicolau, Witold Rużyłło, W. Douglas Weaver, Pierre Theroux, Judith S. Hochman, Thomas G. Filloon, Christopher F. M...> ;Circulation. 2003 Sep 9
• 152 citations
  Aprotinin and the systemic inflammatory response after cardiopulmonary bypass.
  Christopher F. Mojcik, Jerrold H. Levy> ;The Annals of Thoracic Surgery. 2001 Feb 1
• 24 citations
  Co-ligation of alpha4beta1 integrin and TCR rescues human thymocytes from steroid-induced apoptosis.
  Marina Zaitseva, Christopher F. Mojcik, Daniel R. Salomon, Ethan M. Shevach, Hana Golding> ;International Immunology. 1998 Oct 1
• 115 citations
  Adhesion molecules: a rheumatologic perspective.
  Christopher F. Mojcik, Ethan M. Shevach> ;Arthritis and Rheumatism. 1997 Jun 1
• 59 citations
  Vascular Cell Adhesion Molecule-1 Is Expressed by Cortical Thymic Epithelial Cells and Mediates Thymocyte Adhesion. Implications for the Function of α4β1 (VLA4) Integr...
  Daniel R. Salomon, Laura Crisa, Christopher F. Mojcik, Jennifer K. Ishii, George Klier, Ethan M. Shevach> ;Blood. 1997 Apr 1
• 101 citations
  End-stage renal disease and systemic lupus erythematosus.
  Christopher F. Mojcik, John H. Kuppel> ;The American Journal of Medicine. 1996 Jul 1
• 28 citations
  Differential expression of integrins on human thymocyte subpopulations
  Christopher F. Mojcik, Daniel R. Salomon, Andrew C. Chang, Ethan M. Shevach> ;Blood. 1995 Dec 1
• 55 citations
  Alpha 3 beta 1 and alpha 6 beta 1 integrins mediate laminin/merosin binding and function as costimulatory molecules for human thymocyte proliferation.
  A C Chang, Daniel R. Salomon, S. Wadsworth, M.-J. P. Hong, Christopher F. Mojcik, S. Otto, Ethan M. Shevach, John E. Coligan> ;Journal of Immunology. 1995 Jan 15
• 69 citations
  Constitutive activation of integrin alpha 4 beta 1 defines a unique stage of human thymocyte development.
  Daniel R. Salomon, Christopher F. Mojcik, A C Chang, S. Wadsworth, David H. Adams, John E. Coligan, Ethan M. Shevach> ;The Journal of Experimental Medicine. 1994 May 1
• 8 citations
  Role of endogenous retroviruses in autoimmune diseases.
  Mark F. Gourley, Wendy J. Kisch, Christopher F. Mojcik, Leslie B. King, Arthur M. Krieg, Alfred D. Steinberg> ;The Tohoku Journal of Experimental Medicine. 1994 May 1
• 29 citations
  Administration of a phosphorothioate oligonucleotide antisense to murine endogenous retroviral MCF env causes immune effects in vivo in a sequence-specific manner.
  Christopher F. Mojcik, Mark F. Gourley, Dennis M. Klinman, Arthur M. Krieg, Frits Gmelig-Meyling, Alfred D. Steinberg> ;Clinical Immunology and Immunopathology. 1993 May 1
• 7 citations
  Molecular aspects of systemic lupus erythematosus: murine endogenous retroviral expression.
  Mark F. Gourley, Wendy J. Kisch, Christopher F. Mojcik, Leslie B. King, Arthur M. Krieg, Alfred D. Steinberg> ;DNA and Cell Biology. 1992 Apr 1
• Join now to see all